Trial NCT01291784

View at ClinicalTrials.gov 
Org. Study IDs: GCO 10-1450
Secondary IDs: GC1008-JM

Last trial update was posted on 2014-12-08

MeSH Interventions

Antibodies Antibodies, Monoclonal

MeSH Conditions

Polycythemia Polycythemia Vera Primary Myelofibrosis Thrombocythemia, Essential Thrombocytosis

Other Conditions

Myelofibrosis Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase Post-essential Thrombocythemia Related Myelofibrosis

Stopping Reasons

Early termination when the drug was no longer made available by the pharmaceutical company due to unanticipated management and administrative decisions.

Limitations And Caveats

Early termination when the drug was no longer made available by the pharmaceutical company due to unanticipated management and administrative decisions. Limited patient data (2 evaluable patients), a dose accumulation ratio cannot be determined.

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID